Cargando…

Role of Janus Kinase inhibitors in the management of pulmonary involvement due to Long COVID-19 disease: A case control study

OBJECTIVES: Ongoing symptomatic coronavirus disease 2019 (OSC) is defined as persistent symptoms beyond 4 weeks of acute illness. OSC leads to prolonged hospitalization and oxygen dependence. We aimed to find the outcome of Janus kinase inhibitors (JAKi) as a steroid-sparing agent to treat OSC. METH...

Descripción completa

Detalles Bibliográficos
Autores principales:	Singh, Pawan Kumar, Sharma, Vinod Kumar, Lalwani, Lokesh Kumar, Chaudhry, Dhruva, Govindagoudar, Manjunath B., Sriram, Chaudhari Pramod, Ahuja, Aman
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10389097/ https://www.ncbi.nlm.nih.gov/pubmed/37529783 http://dx.doi.org/10.4103/tjem.tjem_363_22

Ejemplares similares

Efficacy of different respiratory supports to prevent hypoxia during flexible bronchoscopy in patients of COPD: a triple-arm, randomised controlled trial
por: Sharma, Vinod Kumar, et al.
Publicado: (2023)

The role of diaphragmatic thickness measurement in weaning prediction and its comparison with rapid shallow breathing index: a single-center experience
por: Lalwani, Lokesh Kumar, et al.
Publicado: (2022)

Tofacitinib Associated with Reduced Intubation Rates in the Management of Severe COVID-19 Pneumonia: A Preliminary Experience
por: Singh, Pawan K, et al.
Publicado: (2021)

COVID-19: Winter is COMING!
por: Chaudhry, Dhruva, et al.
Publicado: (2020)

Indications for Proning in Acute Respiratory Distress Syndrome: Expanding the Horizon!
por: Lalwani, Lokesh K, et al.
Publicado: (2020)

Assessment of knowledge of COVID-19 among health care workers-a questionnaire-based cross-sectional study in a tertiary care hospital of India
por: Singh, Sukhbir, et al.
Publicado: (2021)

Modified Barrier Enclosure for Noninvasive Respiratory Support in COVID-19 Outbreak
por: Kumar, Prashant, et al.
Publicado: (2020)

Assessment of pandemic (COVID-19) preparedness in a teaching hospital in northern India using available (CDC-Atlanta) checklist
por: Singh, Sukhbir, et al.
Publicado: (2021)

Perception of healthcare workers towards ethical aspects of responsiveness of COVID 19 outbreak: A cross-sectional study
por: Singh, Sukhbir, et al.
Publicado: (2022)

Correlation of PaCO(2) and ETCO(2) in COPD Patients with Exacerbation on Mechanical Ventilation
por: Tyagi, Diksha, et al.
Publicado: (2021)

Stridor in a Patient with Uncontrolled Diabetes: An Uncommon Adversary, Successfully Managed with Bronchoscopy
por: Gulia, Kuldeep, et al.
Publicado: (2023)

Hydroxychloroquine for chemoprophylaxis in COVID-19: A case of motivated perception?
por: Manjunath, B.G., et al.
Publicado: (2020)

Ultraviolet Box: An Innovative In-house Use of Ultraviolet Irradiation for Conservation of Respirators in COVID-19 Pandemic
por: Kumar, Prashant, et al.
Publicado: (2020)

Guidelines for the Use of Procalcitonin for Rational Use of Antibiotics
por: Khilnani, Gopi C, et al.
Publicado: (2022)

The Janus kinases (Jaks)
por: Yamaoka, Kunihiro, et al.
Publicado: (2004)

Janus Kinases in Leukemia
por: Raivola, Juuli, et al.
Publicado: (2021)

Left Adrenal Gland Sampling Through Transesophageal Bronchoscopic Ultrasound-Guided Fine Needle Aspiration (EUS-B FNA): A New Route and a New Challenge
por: Parul,, et al.
Publicado: (2022)

Essential Thrombocythemia Due to Janus Kinase 2 Mutation Unmasked After Splenectomy
por: Khanduri, Archana, et al.
Publicado: (2021)

Itch and Janus Kinase Inhibitors
por: HAN, Yujin, et al.
Publicado: (2023)

Therapeutic implications of current Janus kinase inhibitors as anti-COVID agents: A review
por: Jain, Nem Kumar, et al.
Publicado: (2023)

Acneiform Lesions but not Acne after Treatment with Janus Kinase Inhibitors: Diagnosis and Management of Janus Kinase-acne
por: BALLANGER, Fabienne, et al.
Publicado: (2023)

Janus kinase 3 regulates adherens junctions and epithelial mesenchymal transition through β-catenin
por: Mishra, Jayshree, et al.
Publicado: (2017)

Janus kinase inhibitors: jackpot or potluck?
por: Pavithran, Keechilat, et al.
Publicado: (2012)

Janus Kinase Inhibitors and Cell Therapy
por: Assal, Amer, et al.
Publicado: (2021)

Tocilizumab and COVID-19
por: Chaudhry, Dhruva, et al.
Publicado: (2020)

Expression of p38 mitogen-activated protein kinases, glycogen synthase kinase, c-Jun NH2-terminal kinase, extracellular signal-regulated kinase signaling: Can it be used as molecular markers among trauma-hemorrhagic shock patients?
por: Kumar, Manoj, et al.
Publicado: (2016)

Redox regulation of Janus kinase: The elephant in the room
por: Duhé, Roy J
Publicado: (2013)

The rationale for Janus kinase inhibitors for the treatment of spondyloarthritis
por: Veale, Douglas J, et al.
Publicado: (2019)

Clinical significance of Janus Kinase inhibitor selectivity
por: Choy, Ernest H
Publicado: (2019)

Clinical significance of Janus Kinase inhibitor selectivity
por: Choy, Ernest H
Publicado: (2019)

Janus kinase inhibitors for the therapy of atopic dermatitis
por: Traidl, Stephan, et al.
Publicado: (2021)

Role of Janus Kinase Inhibitors in Therapy of Psoriasis
por: Słuczanowska-Głąbowska, Sylwia, et al.
Publicado: (2021)

Janus kinase inhibitors in autoimmune bullous diseases
por: Huang, Dawei, et al.
Publicado: (2023)

Structural basis of Janus kinase trans-activation
por: Caveney, Nathanael A., et al.
Publicado: (2023)

Oclacitinib (APOQUEL®) is a novel Janus kinase inhibitor with activity against cytokines involved in allergy
por: Gonzales, A J, et al.
Publicado: (2014)

Cost-effectiveness of janus kinase inhibitors for rheumatoid arthritis: A systematic review and meta-analysis of cost-utility studies
por: Kumar, S. Sajith, et al.
Publicado: (2022)

Managing Patients With Myelofibrosis in the Era of Janus Kinase Inhibitors
por: Knight, Emily A., et al.
Publicado: (2015)

The Future of Janus Kinase Inhibitors in Inflammatory Bowel Disease
por: De Vries, L.C.S., et al.
Publicado: (2017)

Role of janus kinase inhibitors in the treatment of alopecia areata
por: Triyangkulsri, Korn, et al.
Publicado: (2018)

Impact of Janus Kinase Inhibition on the Treatment of Axial Spondyloarthropathies
por: Hammitzsch, Ariane, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_bpgv6ku8furfbug7et3aqb703n